Literature DB >> 8835509

Comparison of peptides eluted from the groove of HLA-B27 from Salmonella infected and non-infected cells.

J H Ringrose1, B A Yard, A Muijsers, C J Boog, T E Feltkamp.   

Abstract

Reactive arthritis (ReA) is associated with the MHC class-I molecule HLA-B27 and caused by certain Gram-negative bacteria. The mechanism by which HLA-B27 confers a higher susceptibility for this disease compared to other MHC Class-I alleles is still not known. We investigated whether infection of human HLA-B27+ cells is able to change the peptide repertoire presented by these HLA-B27 molecules. To this end large quantities of a B-cell line (C1R-B27) transfected with HLA-B2705 were infected with S. typhimurium. Peptides were eluted from the B27 molecules and separated by Reversed Phase Chromatography (RPC). We then compared the peptide profiles obtained from S. typhimurium infected CIR B-cells with that obtained from non infected cells. Apart from a few additional peaks present in the profile derived from the infected batch the peptide profiles were almost identical. A few fractions were subjected to sequencing by Edman degradation. All peptides found were nonameres with arginine (Arg) at position 2 which is in agreement with the previously described HLA-B27 peptide binding motif. The majority of peaks expressed a mixture of at least four different peptides. The analysis of differences between HLA-B27 bound peptides from Salmonella infected and non infected cells might lead to the identification of T-cell epitopes shared by Salmonella and autoantigens.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8835509     DOI: 10.1007/bf03342652

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  11 in total

1.  Identification of self peptides bound to purified HLA-B27.

Authors:  T S Jardetzky; W S Lane; R A Robinson; D R Madden; D C Wiley
Journal:  Nature       Date:  1991-09-26       Impact factor: 49.962

2.  Phagocytic processing of bacterial antigens for class I MHC presentation to T cells.

Authors:  J D Pfeifer; M J Wick; R L Roberts; K Findlay; S J Normark; C V Harding
Journal:  Nature       Date:  1993-01-28       Impact factor: 49.962

Review 3.  Supply and transport of peptides presented by class I MHC molecules.

Authors:  J C Howard
Journal:  Curr Opin Immunol       Date:  1995-02       Impact factor: 7.486

Review 4.  Current perspectives in reactive arthritis.

Authors:  G Kingsley; J Sieper
Journal:  Immunol Today       Date:  1993-08

5.  A phagosome-to-cytosol pathway for exogenous antigens presented on MHC class I molecules.

Authors:  M Kovacsovics-Bankowski; K L Rock
Journal:  Science       Date:  1995-01-13       Impact factor: 47.728

6.  Characteristics of endogenous peptides eluted from the class I MHC molecule HLA-B7 determined by mass spectrometry and computer modeling.

Authors:  E L Huczko; W M Bodnar; D Benjamin; K Sakaguchi; N Z Zhu; J Shabanowitz; R A Henderson; E Appella; D F Hunt; V H Engelhard
Journal:  J Immunol       Date:  1993-09-01       Impact factor: 5.422

7.  Antigen expressed by Salmonella typhimurium is processed for class I major histocompatibility complex presentation by macrophages but not infected epithelial cells.

Authors:  C V Harding; J D Pfeifer
Journal:  Immunology       Date:  1994-12       Impact factor: 7.397

8.  HLA-B27-restricted CD8 T cells derived from synovial fluids of patients with reactive arthritis and ankylosing spondylitis.

Authors:  E Hermann; D T Yu; K H Meyer zum Büschenfelde; B Fleischer
Journal:  Lancet       Date:  1993-09-11       Impact factor: 79.321

9.  Entrance and survival of Salmonella typhimurium and Yersinia enterocolitica within human B- and T-cell lines.

Authors:  G M Verjans; J H Ringrose; L van Alphen; T E Feltkamp; J G Kusters
Journal:  Infect Immun       Date:  1994-06       Impact factor: 3.441

10.  DR4Dw4/DR53 molecules contain a peptide from the autoantigen calreticulin.

Authors:  F A Verreck; D Elferink; C J Vermeulen; R Amons; F Breedveld; R R de Vries; F Koning
Journal:  Tissue Antigens       Date:  1995-04
View more
  6 in total

1.  Yersinia enterocolitica serotype O:3 alters the expression of serologic HLA-B27 epitopes on human monocytes.

Authors:  M Wuorela; S Jalkanen; J Kirveskari; P Laitio; K Granfors
Journal:  Infect Immun       Date:  1997-06       Impact factor: 3.441

2.  Alteration of HLA-B27 peptide presentation after infection of transfected murine L cells by Shigella flexneri.

Authors:  F Boisgérault; J Mounier; V Tieng; M C Stolzenberg; I Khalil-Daher; M Schmid; P Sansonetti; D Charron; A Toubert
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

3.  Major histocompatibility complex class I peptide presentation after Salmonella enterica serovar typhimurium infection assessed via stable isotope tagging of the B27-presented peptide repertoire.

Authors:  Jeffrey H Ringrose; Hugo D Meiring; Dave Speijer; Theodorus E W Feltkamp; Cecile A C M van Els; Ad P J M de Jong; Jacob Dankert
Journal:  Infect Immun       Date:  2004-09       Impact factor: 3.441

4.  Infection with Salmonella typhimurium has no effect on the composition and cleavage specificity of the 20S proteasome in human lymphoid cells.

Authors:  Miguel Marcilla; José Antonio López de Castro; José G Castaño; Iñaki Alvarez
Journal:  Immunology       Date:  2007-05-09       Impact factor: 7.397

5.  Invasion by Salmonella typhimurium induces increased expression of the LMP, MECL, and PA28 proteasome genes and changes in the peptide repertoire of HLA-B27.

Authors:  W P Maksymowych; T Ikawa; A Yamaguchi; M Ikeda; D McDonald; L Laouar; R Lahesmaa; N Tamura; A Khuong; D T Yu; K P Kane
Journal:  Infect Immun       Date:  1998-10       Impact factor: 3.441

6.  Genetic Susceptibility to Enteric Fever in Experimentally Challenged Human Volunteers.

Authors:  Amber Barton; Jennifer Hill; Sagida Bibi; Liye Chen; Claire Jones; Elizabeth Jones; Susana Camara; Sonu Shrestha; Celina Jin; Malick M Gibani; Hazel Dobinson; Claire Waddington; Thomas C Darton; Christoph J Blohmke; Andrew J Pollard
Journal:  Infect Immun       Date:  2022-03-07       Impact factor: 3.609

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.